Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03906331
Title Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements Yes
Sponsors Loxo Oncology, Inc.
Age Groups: child | senior | adult
Covered Countries USA | NZL | ITA | FRA | ESP | DEU | AUS

Additional content available in CKB BOOST